AIDS-related malignancies: Emerging challenges in the era of highly active antiretroviral therapy.

Abstract

Human immunodeficiency virus (HIV)-infected patients are at increased risk of developing cancer, particularly in the later stages of acquired immune deficiency syndrome (AIDS). Despite the advent of highly active anti-retroviral therapy (HAART), malignan